Form 8-K HERON THERAPEUTICS, INC. For: Aug 08

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Form 8-K HERON THERAPEUTICS, INC. For: Aug 08

FDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst

August 10, 2016 11:14 AM EDT

Leerink affirms Heron Therapeutics (Nasdaq: HRTX) at Outperform with a price target of $33 following FDA approval of Sustol for treatment of chemo induced nausea and vomiting.

Analyst Jason Gerberry commented today: We are still reviewing the package insert, but Sustol... More